MGEN - miRagen Therapeutics up 39% on Orphan Drug tag for Cobomarsen in blood cancer July, 23 2020 05:18 PM Miragen Therapeutics Inc. miRagen Therapeutics (NASDAQ:MGEN) jumps ~39% AH, on the heels of U.S. Orphan Drug tag for Cobomarsen for T-cell lymphoma.More news on: Miragen Therapeutics, Healthcare stocks news, Stocks on the move, Read more ...